Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Fosun International Limited (0656.HK)
Shanghai, CN
Fosun International Limited operates as a global conglomerate, concentrating its diverse activities within the health, lifestyle, wealth management, and advanced manufacturing sectors. Its reach extends across Mainland China, Portugal, and various international territories. The company's comprehensive business model is primarily organized into five distinct segments: Health: This division is dedicated to the research, development, production, distribution, and commercialization of pharmaceuticals, biopharmaceuticals, and other health-related products, complemented by medical and health management services. Happiness: Focused on consumer experiences, this segment manages and invests in businesses related to tourism, leisure, fashion, and broader lifestyle industries. Insurance: Encompasses both the operation of insurance services and strategic investments within the global insurance market. Asset Management: This segment specializes in asset management services and various market investment activities. Intelligent Manufacturing: Involves both direct operations and investment in advanced manufacturing processes, including the production of iron and steel ore. Furthermore, Fosun International engages in capital investment and management, real estate development, retail, and reinsurance. Its extensive operations also include the manufacturing and sale of iron and steel products, provision of banking and financial services, medical consultation, and digital solution delivery. Founded in 1992 and headquartered in Shanghai, China, Fosun International Limited is a subsidiary of Fosun Holdings Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -1.77% | -5.35% | +0.52% | -19.96% | -11.19% | -15.25% | -24.02% | -69.08% | -64.83% | -62.34% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | -1 |
| Buy | 2 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Conglomerates: +6.1%-9.7% Q4'25: -14.8% (vs Q4'23)
-
EPS growth Conglomerates: +16.9%-443.4% Q4'25: -123,433.3% (vs Q4'23)
-
FCF margin FCF growth · Conglomerates: +35.9%+3.4% Q4'25: +8.2% (vs Q4'23)
-
EBIT margin Conglomerates: +9.0%+2.0% Q4'25: -28.3% (vs Q4'23)
-
ROIC Conglomerates: +4.7%+1.9% Q4'25: -53.5% (vs Q4'23)
-
Share dilution Conglomerates: +0.0%-0.1% ★ Q4'25: -0.9% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×15.43× ★ Q4'25: -2.85× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 4 EPS Ana. |
Dec 2027 5 Rev. Ana. 5 EPS Ana. |
Dec 2028 1 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
78.80B
est: 96.78B (-18.6%)
|
73.97B
est: 95.82B (-22.8%)
|
88.03B
est: 94.24B (-6.6%)
|
109.35B
est: 109.55B (-0.2%)
|
142.98B
est: 137.62B (+3.9%)
|
136.74B
est: 161.61B (-15.4%)
|
161.29B
est: 186.34B (-13.4%)
|
182.43B
est: 206.12B (-11.5%)
|
198.20B
est: 208.20B (-4.8%)
|
192.14B
est: 158.01B (+21.6%)
|
173.43B
est: 167.30B (+3.7%)
|
188.20B
177.80B – 198.83B
+12.5% YoY
|
196.36B
184.89B – 206.58B
+4.3% YoY
|
205.82B
194.11B – 216.98B
+4.8% YoY
|
| EBITDA |
-3.91B
est: 4.32B (-190.6%)
|
-1.05B
est: 4.27B (-124.5%)
|
2.22B
est: 4.20B (-47.2%)
|
4.78B
est: 4.89B (-2.3%)
|
9.32B
est: 6.14B (+51.8%)
|
5.02B
est: 7.21B (-30.4%)
|
4.05B
est: 8.31B (-51.2%)
|
1.02B
est: 9.19B (-88.9%)
|
30.50B
est: 9.29B (+228.4%)
|
329.02M
est: 21.87B (-98.5%)
|
14.64B
est: 23.16B (-36.8%)
|
26.05B
24.61B – 27.52B
+12.5% YoY
|
27.18B
25.59B – 28.59B
+4.3% YoY
|
28.49B
26.87B – 30.03B
+4.8% YoY
|
| EBIT |
-8.11B
est: 362.24M (-2,338.5%)
|
20.71B
est: 358.64M (+5,675.8%)
|
28.10B
est: 352.70M (+7,868.4%)
|
28.88B
est: 410.00M (+6,944.4%)
|
37.41B
est: 515.07M (+7,162.2%)
|
-474.76M
est: 604.87M (-178.5%)
|
-1.75B
est: 697.42M (-351.2%)
|
-5.63B
est: 771.47M (-829.2%)
|
19.95B
est: 779.24M (+2,459.7%)
|
-7.09B
est: 7.32B (-196.7%)
|
3.40B
est: 7.75B (-56.2%)
|
8.72B
8.24B – 9.22B
+12.5% YoY
|
9.10B
8.57B – 9.58B
+4.3% YoY
|
9.54B
9.00B – 10.06B
+4.8% YoY
|
| Net Income |
8.04B
est: 8.82B (-8.9%)
|
10.27B
est: 9.32B (+10.1%)
|
13.16B
est: 11.87B (+10.8%)
|
13.41B
est: 11.32B (+18.4%)
|
14.80B
est: 13.45B (+10.0%)
|
8.00B
est: 8.98B (-10.9%)
|
10.08B
est: 10.75B (-6.2%)
|
-831.80M
est: 6.24B (-113.3%)
|
1.38B
est: 1.70B (-18.8%)
|
-4.35B
est: -4.22B (-3.0%)
|
-23.40B
est: -15.20B (-53.9%)
|
2.20B
1.48B – 2.53B
+114.4% YoY
|
2.98B
1.42B – 3.91B
+35.9% YoY
|
3.93B
3.64B – 4.21B
+31.8% YoY
|
| SGA |
16.45B
est: 26.21B (-37.3%)
|
23.37B
est: 25.95B (-9.9%)
|
26.64B
est: 25.52B (+4.4%)
|
36.01B
est: 29.67B (+21.4%)
|
44.02B
est: 37.27B (+18.1%)
|
43.20B
est: 43.77B (-1.3%)
|
50.49B
est: 50.47B (+0.0%)
|
43.57B
est: 55.83B (-21.9%)
|
49.31B
est: 56.39B (-12.6%)
|
45.65B
est: 40.90B (+11.6%)
|
44.37B
est: 43.30B (+2.5%)
|
48.71B
46.02B – 51.46B
+12.5% YoY
|
50.82B
47.85B – 53.47B
+4.3% YoY
|
53.27B
50.24B – 56.16B
+4.8% YoY
|
| EPS |
1.06
est: 1.08 (-2.3%)
|
1.19
est: 1.15 (+3.8%)
|
1.53
est: 1.46 (+4.8%)
|
1.57
est: 1.39 (+12.8%)
|
1.73
est: 1.65 (+4.6%)
|
0.94
est: 1.10 (-14.9%)
|
1.21
est: 1.32 (-8.4%)
|
-0.10
est: 0.77 (-113.0%)
|
0.17
est: 0.21 (-18.6%)
|
-0.53
est: -0.52 (-2.0%)
|
-2.88
est: -1.87 (-53.9%)
|
0.27
0.18 – 0.31
+114.4% YoY
|
0.37
0.17 – 0.48
+35.9% YoY
|
0.48
0.45 – 0.52
+31.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.13% | 151.5K | 0.42% |
| 2 | WisdomTree China ex-State-Owned Enterprises Fund CXSE | 0.11% | 528.4K | 0.32% |
| 3 | HSBC Emerging Market Screened Equity UCITS ETF HSEM.L | 0.10% | 293.3K | 0.18% |
| 4 | HSBC Asia Pacific Ex Japan Screened Equity UCITS ETF HSXD.L | 0.07% | 514.3K | 0.25% |
| 5 | Franklin FTSE China ETF FLCH | 0.04% | 112.4K | 0.19% |
| 6 | Franklin FTSE China UCITS ETF FLXC.L | 0.04% | 610.0K | 0.19% |
| 7 | WisdomTree Emerging Markets ex-State-Owned Enterprises Fund XSOE | 0.04% | 771.1K | 0.32% |
| 8 | Avantis Emerging Markets Equity ETF AVEM | 0.02% | 5.78M | 0.33% |
| 9 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.02% | 54.3K | 0.35% |
| 10 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing VDEM.L | 0.01% | 620.2K | 0.17% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Xiaoliang Xu | Co-CEO & Executive Director | 41M | male |
| Qiyu Chen | Co-CEO & Executive Director | 41M | male |
| Guangchang Guo | Executive Chairman | 39M | male |
| Qunbin Wang | Executive Co-Chairman | 38M | male |
| Ping Gong | Executive President, Chief Financial Officer & Executive Director | 15M | male |
| Donghui Pan | Executive President, Chief Human Resources Officer & Executive Director | 13M | male |
| Zhen Huang | Executive Director | 7M | male |
| Sun Lu | General Manager of Capital Market and Investor Relations | — | — |
| Fan Ruohan | Senior Assistant to the President & Chief Technology Officer | — | — |
| Bin Tang | Chief Investment Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 0656.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
